Maiwald Magazine

Press Coverage

15 Apr 2025 - Press Coverage

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Cyprumed GmbH and Merck & Co., Inc. have entered a Non-Exclusive License and Option Agreement to develop oral formulations of peptides using Cyprumed’s drug delivery technology. MSD gains global non-exclusive rights...

2 Apr 2025 - Press Coverage

Managing IP names Maiwald one of the leading IP law firms in Germany

The market analysis by Managing IP and the IP STARS ranking 2024 confirm this: The German market for intellectual property remains dynamic and highly competitive. Especially in the field of patent law, numerous law firms were able to maintain and expand their leading positio...

11 Mar 2025 - Press Coverage

Roche gets Illumina unit’s DNA testing patent revoked

Roche has successfully persuaded a European appeals panel to revoke a patent held by Illumina’s subsidiary, Verinata Health, for detecting fetal DNA in maternal blood. The European Patent Office (EPO) ruled that the patent lacked an inventive step, as a prior application f...

Maiwald in the press

Publications

11 Jun 2025 - Publication

Managing IP Awards interview: Maiwald
ManagingIP June 10, 2025

In their recent feature with Managing IP, senior representatives from Maiwald – Dr. Anja Fux, Dr. Derk Vos, Heike Roeder-Hitschke, Dr. Nils Braun and Martina Boidol...

30 Apr 2025 - Publication

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

This article covers the most recent developments regarding the European Research Exemption, which permits the use of patented inventions for research purposes, as well as the ...

30 Apr 2025 - Publication

The ‘long-arm’ of the Unified Patent Court – New developments in European cross-border patent litigation, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

The jurisdictional reach of the Unified Patent Court (UPC) was a widely and controversially discussed topic from the outset. Some practitioners took the view that the UPC also...

All publications

Events

Sun.

28 Sep 2025 |Upcoming|External Events

Maiwald at TMAP 2025 in Berlin, September 28-30, 2025

We are pleased to participate in the INTA Trademark Administrators & Practitioners (TMAP) Meeting 2025 in Berlin. This prestigious event brings together trademark administrators, patent paralegals, young professionals and attorneys working in the field of trademark law.The diverse conference program will cover current developments in trademark law and practical top...

Wed.

21 May 2025 |Past Event|External Events

C5’s 18th Annual Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam

We are pleased to announce that Dr. Eva Susanne Ehlich will be an expert at the 18th C5 Communications Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam. Eva will give a presentation on “Plausibility and Post-Publicatio...

Tue.

20 May 2025 |Past Event|Vortag Live

Joint symposium with Oblon in Tokyo on May 20, 2025

The Oblon and Maiwald firms were pleased to host a complimentary joint international symposium on:U.S. and European Patent Practice: Important Aspects for Practitioners At the 2025 joint symposium, selected current aspects of protecting innovations in the U.S. and Europe were examined, considering bo...

Sat.

17 May 2025 |Past Event|External Events

Maiwald at INTA’s 2025 Annual Meeting in San Diego

The International Trademark Association's (INTA) Annual Meeting took place in San Diego from May 17 to 21 this year. Maiwald was among the many companies and law firms in attendance, represented by Susanna Heurung,

All events

News and Releases

Maiwald Blog

Turn one into several – what Rule 80 EPC says about using several independent claims to defend one independent claim

EPO Board of Appeal 3.3.04 is setting the right standard for acknowledging novelty of non-medical use claims (T 1913/21)

EPO revokes Roche’s Patent on combination therapy of bevacizumab and paclitaxel for platinum-resistant ovarian cancer that was supported by results of Phase III AURELIA clinical trial

Press Coverage

Cyprumed Enters License and Option Agreement with MSD for the Development of Oral Peptide Therapeutics

Managing IP names Maiwald one of the leading IP law firms in Germany

Roche gets Illumina unit’s DNA testing patent revoked

Staff News

Dr. Patrick Heeger and Dr. Andre Mähringer sworn in as German patent attorneys

Maiwald congratulates Dr. Anna Closs on passing the exam

Maiwald appoints Dr. Lukas Delvos and Dr. Jian Sun as Counsel

Publications

Managing IP Awards interview: Maiwald
ManagingIP June 10, 2025

Safe Harbor Provision in European Patent LawThe Research & Bolar Exemptions, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

The ‘long-arm’ of the Unified Patent Court – New developments in European cross-border patent litigation, AIPLA Chemical Practice Chronicles Newsletter, Volume 13 Issue 1 2025

Awards

Leaders League Ranking Germany 2025

Maiwald honoured by Managing IP for more than ten years

Maiwald awarded by the Financial Times

Events

Maiwald at TMAP 2025 in Berlin, September 28-30, 2025

C5’s 18th Annual Forum on “Pharma & Biotech Patent Litigation in Europe” in Amsterdam

Joint symposium with Oblon in Tokyo on May 20, 2025

Maiwald at INTA’s 2025 Annual Meeting in San Diego